Aureon Labs Raises $18 Million

Aureon Laboratories, a New York-based developer of analytics focused on predictive cancer treatment options, has called down $7 million of an $18 million funding round, according to a regulatory filing. Return backers include Atlas Venture, New Leaf Venture Partners and Pfizer Inc. The company previously raised around $62 million. www.aureon.com